Cefepime Dosing for Creatinine Clearance of 22 mL/min
For patients with creatinine clearance of 22 mL/min, the recommended dose of cefepime is 1 gram every 24 hours. 1
Dosing Considerations in Renal Impairment
- Cefepime is primarily excreted by the kidneys, requiring dose adjustment in patients with renal impairment to prevent drug accumulation and potential toxicity 1
- A creatinine clearance of 22 mL/min represents moderate to severe renal impairment, necessitating significant dose reduction from the standard dosing regimen 1
- According to the FDA drug label, patients with creatinine clearance less than or equal to 60 mL/min require dosage adjustment to compensate for slower renal elimination 1
Specific Dosing Recommendations
- For patients with creatinine clearance between 11-29 mL/min, the recommended dose is 1 gram every 24 hours 1
- This represents a 50% reduction in daily dose compared to patients with normal renal function who typically receive 1-2 grams every 12 hours 1
- The extended dosing interval (24 hours instead of 12 hours) helps maintain therapeutic drug levels while preventing toxic accumulation 2
Monitoring Considerations
Patients with renal impairment receiving cefepime should be carefully monitored for signs of neurotoxicity, which may include:
Plasma levels of cefepime can vary significantly between individuals with renal impairment, with up to 40-fold differences in trough concentrations reported in some studies 2
Risks of Inappropriate Dosing
- Serious adverse events have been reported in patients with renal impairment given unadjusted doses of cefepime, including life-threatening or fatal occurrences of encephalopathy, myoclonus, and seizures 1
- Studies have shown that even with dose adjustment, approximately 10% of patients with severe renal impairment (CrCl < 30 mL/min) may still experience cefepime accumulation with trough concentrations of 20-30 mg/L 2
- Symptoms of cefepime overdose in renal impairment include encephalopathy, confusion, hallucinations, stupor, coma, myoclonus, seizures, and neuromuscular excitability 1
Special Considerations
- Hemodialysis contributes to cefepime clearance, so for patients on dialysis, cefepime should be administered after dialysis sessions 4
- For elderly patients with renal impairment, extra caution is warranted as they may be at higher risk for adverse effects due to age-related decreases in renal function 1
- If signs of neurotoxicity develop, prompt discontinuation of cefepime should be considered, as symptoms typically resolve after drug cessation 5
Common Pitfalls to Avoid
- Failing to adjust cefepime dosage in patients with renal impairment, which can lead to drug accumulation and neurotoxicity 1, 2
- Not recognizing early signs of cefepime-associated neurotoxicity, which may be subtle and mistaken for other conditions common in critically ill patients 3
- Inadequate monitoring of renal function during treatment, as changes in renal function may necessitate further dose adjustments 1
- Using standard dosing in elderly patients without considering age-related decreases in renal function 1